HAS Authority Over Cancer Program Become Hot Issues; Fredrickson Opposes Exemption For NCI
In Brief: Cancer Claims Morris Kupchan, Who Found Promising New Antitumor Drugs In Plants
L-PAM Benefit To Post-Menopausal Patients Challenged
NCI Relates FDA Instructions On Latest IND Delays
Two Workshops To Look For New Research Areas
Proposed Regulations for Center Grants In Federal Register
Obey Attacks NCI In Campaign Speech
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Trump targets HHS in $810M appropriations clawback
- Two years after FDA’s breast density notification rule, there is still no standard for follow-up
So far, 38 million patients have received a dense breast notification. Now what?









